We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Book Reviews |

Physician's Guide to Drug Eruptions

Arch Pediatr Adolesc Med. 2000;154(2):208-209. doi:10.1001/archpedi.154.2.208.
Text Size: A A A
Published online


Drug eruptions are probably the most common iatrogenic group of ailments and they will continue to become more common with the ever-increasing consumption of medications and the development of new drugs. Even though the internal organs, particularly the liver, suffer more than the skin from the adverse effects of drug use, any eruption obviously comes to attention early and is often alarming. Unfortunately, almost none of these eruptions are pathognomonic of any drug and, hence, they often constitute a diagnostic dilemma to the prescribing physician as well as to the consultants in dermatology and allergy. The problem is further compounded by the lack of specific diagnostic tests, albeit for allergy skin testing for a few antibiotics and hormones. The diagnosis basically depends on a high index of clinical suspicion coupled with experience in differential diagnosis of rashes. The causal relationship can be confirmed by documenting rapid clearance of the rash following discontinuation of the suspected drug(s) and its recurrence on reintroduction. However, such a procedure is often not done, particularly when it is associated with a high risk, which results in the overdiagnosis of drug-induced eruptions that are frequently mistaken for drug allergies. On the other hand, missing the diagnosis of a drug eruption would risk individual re-exposure to the same drug, or to a cross-reacting one, with potentially grave consequences.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.